Publication | Closed Access

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study

Heart FailureFibrosisHealth SciencesCardiovascular DiseaseMyocardial InfarctionFibroblast Growth FactorCardiologyVascular BiologyDose Escalation StudyVascular Endothelial Growth FactorMedicineRadiation OncologyAtherosclerosisCardiovascular Imaging